About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Ohio | 525 Studies

Clinical Trials Prostate CancerOhio

Prostate Cancer Clinical Trials in Ohio

Find 525 clinical trials for prostate cancer near Ohio. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Ohio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 121-140 of 525 trials

Active not recruitingAn International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)The purpose of this study is to evaluate the efficacy and safety of 177Lu-PSMA-617 in combination with Standard of Care (SOC), versus Standard of Care alone, in adult male…NCT04720157·Scottsdale, Arizona and 163 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingA Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyThe purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutamide from the subjects…NCT02960022·Anchorage, Alaska and 232 others

Approved for marketingStudy of Abiraterone Acetate in Patients With Advanced Prostate CancerThe purpose of this study is to collect additional safety information on abiraterone acetate administered with prednisone to patients with metastatic castration-resistant prostate…NCT01217697·Birmingham, Alabama and 296 others

CompletedAndrogen Suppression Plus Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells.NCT00006359·Lewes, Delaware and 25 others

Active not recruitingTalazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPCThis study compares rPFS in men with mCRPC treated with talazoparib plus enzalutamide vs. enzalutamide after confirmation of the starting dose of talazoparib in combination with…NCT03395197·Anchorage, Alaska and 369 others

SuspendedThe Plenaxis® Experience StudyPraecis is currently conducting a 2000 patient Experience Study; this is a Phase IV commitment postmarketing safety study in the Food and Drug Administration (FDA) indicated…NCT00103623·Birmingham, Alabama and 59 others

RecruitingStudy Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)This is a four-part study evaluating the safety and efficacy of a PSMA-directed radioantibody (rosopatamab tetraxetan, conjugated to either In-111 or Ac-225).NCT06549465·San Diego, California and 8 others

CompletedSafety and Efficacy of TAK-385 for Patients With Localized Prostate CancerThe purpose of this study is to evaluate the efficacy of TAK-385 for achieving and maintaining testosterone suppression.NCT02135445·Birmingham, Alabama and 24 others

CompletedMagnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate CancerThis pilot clinical trial studies magnetic resonance (MRI)-guided focal stereotactic radiosurgery (SRS) in treating patients with low- or intermediate-risk localized prostate…NCT02163317·Cleveland, Ohio

CompletedRadiation Therapy With Androgen Suppression in Treating Patients With Prostate CancerRATIONALE: Imaging procedures such as MRI may improve the ability to determine the response of prostate tumors to therapy.NCT00002889·San Francisco, California and 11 others

Active not recruitingNivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary TumorsThis research study is studying a combination of drugs as a possible treatment for rare genitourinary malignancies among four cohorts, bladder or upper tract carcinoma with…NCT03333616·La Jolla, California and 5 others

Active not recruitingTo Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close MonitoringThis phase II trial studies how well green tea catechins work in preventing progression of prostate cancer from a low risk stage to higher risk stages in men who are on active…NCT04597359·Fairbanks, Alaska and 352 others

Active not recruitingPhase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate CancerThe purpose of this study is to evaluate the effectiveness of ProstAtak® immunotherapy in combination with radiation therapy for patients with intermediate-high risk localized…NCT01436968·Gilbert, Arizona and 72 others

TerminatedLeuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate CancerRATIONALE: Inserting the gene for interleukin-2 into a person's cancer cells may improve the body's ability to fight cancer.NCT00004050·Los Angeles, California and 1 other

CompletedRadiation Therapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells.NCT01434290·Birmingham, Alabama and 36 others

TerminatedStudy of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate CancerBone metastases and associated pain are a major cause of morbidity and mortality in castration-resistant prostate cancer (CRPC).NCT01522443·Scottsdale, Arizona and 81 others

CompletedReiki/Energy Healing in Prostate CancerThe purpose of this study is to determine whether Reiki energy healing affects anxiety and disease progression in patients with localized prostate cancer who are candidates for…NCT00065208·Cleveland, Ohio

CompletedStudy of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid TumorsThis is a Phase Ib/II, multicenter, open-label study to evaluate the safety and preliminary efficacy of TT-00420 tablet, as monotherapy or in combination regimens, in patients…NCT04742959·Duarte, California and 5 others

RecruitingTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsThis phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from…NCT03866382·Birmingham, Alabama and 581 others

RecruitingTesting Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL TrialThis randomized phase III trial examines whether lengthening the dosage interval in an adaptive manner for the prostate cancer drug lutetium 177 Lu PSMA RLT improves quality of…NCT07200830·Anchorage, Alaska and 141 others

PreviousPage 7 of 27Next

Other Conditions in Ohio

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma